Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Naturally Splendid Enterprises Ltd V.NSP.H

Alternate Symbol(s):  NSPDF

Naturally Splendid Enterprises Ltd. is a Canada-based company, which develops and distributes healthy lifestyle foods and products. The Company owns Prosnack Natural Foods Inc. (Prosnack Natural Foods), a food manufacturing facility. Prosnack Natural Foods focusses on nutritional bars, Chii Naturally Pure Hemp, which is a retail line of hemp food products, while Pawsitive FX is a line of all natural balms for dogs. The Company has also developed technologies for the extraction of healthy omega three and six oils, as well as a protein concentrate from hemp. It focuses on manufacturing and distributing an extensive line of plant-based, meat-alternative entrees. It offers functional foods under brands, such as Natera Sport, Natera Hemp Foods, CHII and Elevate Me.


TSXV:NSP.H - Post by User

Comment by Todamoon18on Nov 04, 2020 6:48pm
192 Views
Post# 31839706

RE:Franco Cavaleri 5:47 min video - a must watch!

RE:Franco Cavaleri 5:47 min video - a must watch!
dontknowmuch wrote:  
NSP greenlit to begin Phase 2 study for its potential COVID-19 treatment

Biologic Pharmamedical CEO Franco Cavaleri tells Proactive the group, together with Naturally Splendid Enterprises Ltd (CVE:NSP) (OTCQB:NSPDF) has received a Notice of Authorization from Health Canada to proceed with a Phase 2 clinical trial for a potential COVID-19 treatment utilizing the target drug Cavaltinib.

Cavaleri says within 60-90 days the company should be able to begin the trial. Cavaleri says he hopes Cavaltinib will show positive results in mitigating the 'cytokine storm' with COVID-19 patients.

*****
Be safe!

*****

Living in the sunshine
Always DYODD
DKM




LOL a must watch?For what?To fall asleep to?
Are you paid by the company?...because you seem really weird!


<< Previous
Bullboard Posts
Next >>